SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending as investors react to a clinical trial update confirming 78 events in the pivotal REGAL study, bringing the company closer to the 80-event trigger for data unblinding. Community discourse remains highly polarized, with intense debate centered on the timing of the final results, the company's strong cash position, and widespread speculation regarding potential buyout interest from big pharma.

Everspin Technologies, Inc. engages in the provision of magnetoresistive random access memory (MRAM) solutions. Its products include Toggle MRAM, Spin-transfer Torque MRAM, TMR Sensors, and Embedded MRAM. The company was founded by Saied Tehrani on May 16, 2008 and is headquartered in Chandler, AZ.

Everspin Technologies Inc

Everspin Technologies is seeing intense volatility as retail investors drive a potential gamma squeeze, drawing parallels to past momentum runners in the semiconductor and memory sectors. Community sentiment is overwhelmingly bullish, with many focused on the stock's role in Edge AI infrastructure and speculating that limited float could fuel significant further upside.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending as investors react to the NRC's approval of the Principal Design Criteria for its Aurora powerhouse, a major regulatory milestone that de-risks the path toward commercial deployment. The community remains highly focused on the company's pre-revenue status, with active debate surrounding management's cash burn, upcoming earnings, and the stock's potential for a short squeeze given its high interest and critical role in the expanding AI energy infrastructure.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is experiencing significant market interest driven by reports that Nelson Peltz's Trian Fund Management is actively seeking financing to take the company private. This potential buyout, coupled with a high level of short interest, has led the community to actively discuss the setup for a potential short squeeze as investors bet on the company's long-term value despite recent downward analyst pressure.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing high volatility as investors navigate a broader semiconductor sector pullback, with the community actively debating whether the decline represents a healthy consolidation amid strong AI-driven memory demand or the beginning of a larger correction. While bearish sentiment highlights concerns over extreme valuations and potential supply-chain disruptions, many long-term bulls are aggressively purchasing the dip, citing strong fundamental growth and upcoming earnings catalysts.

WORK Medical Technology Group Ltd. engages in the development of health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.

Work Medical Technology Group Ltd - Ordinary Shares - Class A

Work Medical Technology Group Ltd

Work Medical Technology Group Ltd (WOK) has become a focal point of intense community discussion, driven by extreme price volatility and a series of intraday trading halts that have fueled both massive short squeezes and aggressive profit-taking. Traders are actively debating whether the stock's parabolic moves, which echo typical patterns seen in other high-risk Chinese micro-cap tickers, represent a genuine growth catalyst or an unsustainable pump-and-dump setup.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is gaining momentum as investors pivot toward its potential in AI data center infrastructure and defense, with the community closely tracking institutional accumulation and rumors of upcoming OEM partnerships. Sentiment remains sharply divided between long-term holders betting on the company's solid-state battery technology and traders frustrated by periods of consolidation and the lack of immediate contract announcements.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is attracting significant investor attention as they debate whether the stock is a deep-value opportunity or a value trap, with the community closely tracking the company's transition toward agentic AI orchestration and enterprise integration partnerships. While investors express frustration over persistent share price weakness and perceived market manipulation, others are aggressively accumulating shares, citing UiPath's strong cash position, debt-free balance sheet, and long-term growth potential as the market rotates back toward quality AI software.

Rackspace Technology, Inc. engages in the provision of end-to-end multi-cloud technology services. The firm designs, builds and operates its customers’ cloud environments across technology platforms. It operates through the following segments: Multicloud Services and Apps & Cross Platform. The Multicloud Services segment includes public and private cloud managed services offerings, as well as professional services related to designing and building multicloud solutions and cloud-native applications. The Apps & Cross Platform segment includes managed applications, managed security and data services, as well as professional services related to designing and implementing application, security and data services. The company was founded on July 21, 2016 and is headquartered in San Antonio, TX.

Rackspace Technology Inc

Rackspace Technology is seeing significant trading volume and bullish sentiment driven by its recent MOU with AMD to develop governed enterprise AI infrastructure. The community is actively debating the stock's potential as an AI-infrastructure play versus concerns regarding its debt load and potential share dilution.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is trending as investors aggressively scrutinize the company's ability to translate defense partnerships and production capacity into tangible revenue ahead of its upcoming earnings report. The community is debating management's transparency and communication style while closely monitoring the stock's high short interest and potential catalysts from government drone procurement initiatives.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Here Are Monday's Top Wall Street Analyst Research Calls: Dell Technologies, BioMarin Pharmaceutical, Disney, HubSpot, Klarna, Oklo, Pitney Bowes, Trade Desk, Wendy's, and More

Here Are Monday's Top Wall Street Analyst Research Calls: Dell Technologies, BioMarin Pharmaceutical, Disney, HubSpot, Klarna, Oklo, Pitney Bowes, Trade Desk, Wendy's, and More...

Sanford C. Bernstein Cuts BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target to $82.00

Sanford C. Bernstein reduced their target price on shares of BioMarin Pharmaceutical from $94.00 to $82.00 and set an "outperform" rating for the company in a report on Tuesday...

BioMarin Q1 Earnings Miss, Sales Beat, '26 Revenue Guidance Raised

BMRN misses Q1 EPS estimates despite a revenue beat, as charges and higher costs weigh on profits, while new Amicus deal lifts the 2026 outlook.

BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Lowered to $119.00 at Morgan Stanley

Morgan Stanley lowered their price target on shares of BioMarin Pharmaceutical from $120.00 to $119.00 and set an 'overweight' rating on the stock in a report on Tuesday...

Royal Bank Of Canada Reaffirms Sector Perform Rating for BioMarin Pharmaceutical (NASDAQ:BMRN)

Royal Bank Of Canada reissued a "sector perform" rating and set a $66.00 price target on shares of BioMarin Pharmaceutical in a research report on Tuesday...

Compared to Estimates, BioMarin (BMRN) Q1 Earnings: A Look at Key Metrics

Although the revenue and EPS for BioMarin (BMRN) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

BioMarin Pharmaceutical Q1 Earnings Call Highlights

BioMarin Pharmaceutical (NASDAQ:BMRN) executives emphasized an expanded commercial portfolio and an updated 2026 growth outlook during the company's first-quarter 2026 earnings call, highlighted by...

Transcript: Biomarin Pharmaceutical Q1 2026 Earnings Conference Call

BioMarin Pharmaceutical (BMRN) Q1 Earnings Lag Estimates

BioMarin (BMRN) delivered earnings and revenue surprises of -18.96% and +0.50%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

BioMarin Pharmaceutical (NASDAQ:BMRN) Issues Earnings Results

BioMarin Pharmaceutical (NASDAQ:BMRN - Get Free Report) posted its earnings results on Monday. The biotechnology company reported $0.76 earnings per share for the quarter, missing analysts' consensus estimates of $0.94 by ($0.18). The business had revenue of $766.21 million for the quarter...

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.

BMRN
Biomarin Pharmaceutical Inc. - Registered Shares

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BMRN News

BMRNBiomarin Pharmaceutical Inc. - Registered Shares